Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the first patient has been dosed in a...
Ginkgo Bioworks — the leading horizontal platform for cell programming — and the biotechnology company Zymergen announced they have entered into a definitive agreement...
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
Rona Therapeutics, Inc ("Rona"), a fully integrated platform company dedicated to the discovery, development and manufacturing of RNA therapeutics, announced that it has obtained...
